Aptahem’s patent family 2 in Europe has been finalized by validation in the 11 countries where applied

Aptahem AB (publ) announces today that in all countries in Europe where the company has applied for patent protection now have validated and approved the patent family 2. The patent has been published with patent number 3691655. With these...

Read More

BioStock article: Aptahem’s new research findings explained

BioStock published an article on 2 December 2021 about Aptahem, which can be read in full below. Aptahem’s collaboration with Örebro University recently led to a research breakthrough regarding a newfound pharmacological mechanism behind Aptahem’s sepsis treatment Apta-1. BioStock...

Read More